Hearing

ADW Capital Management Sends Letter to GFL Environmental’s Board and Management Encouraging it to Undertake a Strategic Review Process

Retrieved on: 
Monday, November 6, 2023
Consensus, GFL, IPO, CAD, People (magazine), Waste management, Hockey, NYSE, KEEP, Thought, History, EBITDA, Research, Consensus decision-making, Letter, Growth, Risk, Investment, National Enquirer, NTM, ALL, TSX, Hearing, MIAMI, Natural gas, Management, Security (finance)

MIAMI BEACH, Fla., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ADW Capital Management, LLC, which owns 1,650,000 shares of GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) (the “Company”) together with its affiliates, today issued an open letter to GFL’s board of directors and management team regarding opportunities to maximize value for all shareholders and urging the Company to undertake a strategic review process.

Key Points: 
  • A full copy of the letter is below:
    Dear Members of the Board and Management:
    ADW Capital Management, LLC, together with its affiliates (collectively, “ADW Capital” or “we”) are significant and long-term shareholders of GFL Environmental Inc. (“GFL”, or the “Company”), currently owning 1,650,000 of the Company’s shares.
  • We believe GFL is an extremely valuable company that the public markets are unable to appreciate today and perhaps never will be able to.
  • The multiple differential relative to its competitors is even more perplexing given its faster growth profile and prospects for future margin expansion.
  • The Board and management have a fiduciary obligation to maximize value for ALL shareholders and we encourage them to immediately engage a financial advisor to pursue a review of strategic alternatives.

Study: Brain Training Improves Cognitive Function In Multiple Sclerosis

Retrieved on: 
Monday, November 6, 2023
Attention, Ageing, Medicare, SDMT, Dementia, Research, Exercise, Quality of life, Memory, Deficit spending, Posit Science Corporation, Movement, Patient, Grammatical mood, Hearing, Cognition, MS, Central nervous system, Pharmaceutical industry, Nursing

While often associated with motor control issues, MS also commonly includes cognitive and neurological challenges.

Key Points: 
  • While often associated with motor control issues, MS also commonly includes cognitive and neurological challenges.
  • Diminished speed of information processing, which can affect both movement and cognition, is one of the most common cognitive deficits .
  • These results confirm and extend findings in prior studies of cognitive training in MS, including seven prior studies using BrainHQ .
  • The study report concludes: “This study provides evidence that computerized cognitive training with BrainHQ is a valuable option for [people with MS] suffering from cognitive decline.

November 2023 Letter to Shareholders

Retrieved on: 
Friday, November 3, 2023
FDA, Policy, Compensated emancipation, G&A, HIV, Workforce, Injection, Leronlimab, Sidley Austin, Drug development, Professional Football Compensation Committee, Clinical trial, Compensation, Partnership, Consultant, Benchmarking, FAQ, FBI investigation into Donald Trump's handling of government documents, Annual report, IP, Patient, MASH, Hearing, Lifting, Communication, Security (finance), Pharmaceutical industry, Retail, Management

If successful, our current team stands ready to implement the best strategies to maximize shareholder value in the near- and long-term.

Key Points: 
  • If successful, our current team stands ready to implement the best strategies to maximize shareholder value in the near- and long-term.
  • The Company recently provided additional information to the FDA that we believe answers the FDA’s remaining questions.
  • Accordingly, each fiscal year, the shareholders are asked to place an advisory vote as to the compensation of our executive officers.
  • Risk Factors”, as later supplemented by our Form 10-Q for the quarter ended August 31, 2023, in the section captioned “Item 1A.

Oxford Square Capital Corp. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 7, 2023

Retrieved on: 
Thursday, November 2, 2023
Hearing, Nightclub, Internet service provider

Greenwich, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ ) (NasdaqGS: OXSQL) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) announced today that it will hold a conference call to discuss third quarter 2023 earnings on Tuesday, November 7, 2023 at 9:00 AM Eastern time.

Key Points: 
  • Greenwich, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ ) (NasdaqGS: OXSQL) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) announced today that it will hold a conference call to discuss third quarter 2023 earnings on Tuesday, November 7, 2023 at 9:00 AM Eastern time.
  • The toll free dial-in number is 1-833-470-1428, access code number 495860.
  • There will be a recording available for 30 days after the call.
  • If you are interested in hearing the recording, please dial 1-866-813-9403.

Warrantee Inc. Announces Receipt of Nasdaq Delisting Determination; Plans to Appeal

Retrieved on: 
Thursday, November 2, 2023
Security (finance), Eastern Time Zone, American depositary receipt, Marketing, Letter, Hearing, Cryptocurrency

Nasdaq explained in the Letter that the Company’s noncompliance with the first required periodic report after listing raised questions regarding the Company’s ability and readiness to be a Nasdaq listed company.

Key Points: 
  • Nasdaq explained in the Letter that the Company’s noncompliance with the first required periodic report after listing raised questions regarding the Company’s ability and readiness to be a Nasdaq listed company.
  • This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.
  • The Letter stated that the Company may appeal Staff’s determination to a Hearings Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series.
  • The Company intends to request a hearing to appeal the Staff’s delisting determination and an extended stay by 4:00 p.m. (Eastern Time) on November 3, 2023.

Eargo Celebrates 1-Year Anniversary of FDA's Over-the-Counter (OTC) Hearing Aid Regulations, Driving a New Era of Accessibility and Innovation

Retrieved on: 
Wednesday, November 1, 2023
FDA, UnitedHealth Group, Social, Insurance, Kool-Aid, Health, Medicare, Hearing loss, Congress, OTC, US Foods, Quality of life, EAR, Hearing, SAN, Pharmaceutical industry, Life insurance, Eargo

SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo”) celebrates the one-year anniversary of the creation of an over-the-counter (OTC) hearing aid category in the US.

Key Points: 
  • SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo”) celebrates the one-year anniversary of the creation of an over-the-counter (OTC) hearing aid category in the US.
  • Approximately 75% of Eargo survey respondents who had previously worn a traditional hearing aid indicated that Eargo’s performance was equal to or better than their traditional hearing aid.
  • To date, most plans have made no changes to the hearing aid benefits offered, and a handful of plans exclude coverage of OTC hearing aids.
  • Eargo’s commitment to accessibility and innovation envisions a future where hearing care is transformative and accessible to all Americans who need it.

T2 Biosystems Regains Compliance with Nasdaq Listing Requirements

Retrieved on: 
Wednesday, November 1, 2023
Hearing, Cryptocurrency, Auction

LEXINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that on October 31, 2023 it received written notice from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company regained compliance with the minimum bid price requirement (the “Minimum Bid Price Requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market.

Key Points: 
  • LEXINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that on October 31, 2023 it received written notice from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company regained compliance with the minimum bid price requirement (the “Minimum Bid Price Requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market.
  • The Company had previously been notified by the Nasdaq on March 20, 2023 that it was not in compliance with the Minimum Bid Price Requirement because its common stock had failed to maintain a minimum bid price of $1.00 for 30 consecutive business days.
  • However, the Company will have an opportunity to request a new hearing with the Nasdaq Listing Qualifications Hearing Panel prior to the Company’s securities being delisted from Nasdaq.
  • As previously reported, T2 Biosystems received written notice from the Nasdaq on August 8, 2023 informing the Company that it had regained compliance with the market value of listed securities (“MVLS”) requirement, as set forth in Nasdaq Listing Rule 5450(b) for continued listing on the Nasdaq Capital Market.

NCLA Petitions en Banc Sixth Circuit to Halt Government-Directed Social Media Censorship

Retrieved on: 
Tuesday, October 31, 2023
Supreme court, HHS, Social media, Government, White House, Same-sex marriage in the Sixth Circuit, NCLA, Human services, Constitutional right, Massachusetts v. United States Department of Health and Human Services, Senger, Speech, United States Court of Appeals for the Sixth Circuit, Complaint, First Amendment to the United States Constitution, United States courts of appeals, White, House, United States Court of Appeals for the Fifth Circuit, En banc, Hearing, The central science, COVID-19, First, Changizi

asking an en banc U.S. Court of Appeals for the Sixth Circuit, or the three-judge panel, to rehear the case and halt the government’s unconstitutional assault on free speech.

Key Points: 
  • asking an en banc U.S. Court of Appeals for the Sixth Circuit, or the three-judge panel, to rehear the case and halt the government’s unconstitutional assault on free speech.
  • Biden Administration officials, including some within the Department of Health and Human Services, have violated the First Amendment by directing social media companies to censor viewpoints that conflict with the government’s Covid-19 messaging.
  • The en banc Sixth Circuit should correct the panel’s error and allow the Changizi plaintiffs to continue their lawsuit seeking to put a stop to the government’s extensive social media censorship activities.
  • We urge the Sixth Circuit, sitting en banc, or the panel itself, to rehear the case and correct this error.”

Hearing Industries Association Announces Bridget Dobyan as Incoming Executive Director, Succeeding Kate Carr

Retrieved on: 
Monday, October 30, 2023
Policy, Kate, Public policy, Human, OTC, Federation, Hemp Industries Association, Carr, Lead, HIA, Catherine Carr, Hearing, Management

Washington D.C., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Hearing Industries Association (HIA), the only American association to represent hearing aid technology, announces the selection of Bridget Dobyan to serve as Executive Director, effective January 1, 2024, succeeding current President, Kate Carr, who will retire on December 31, 2023.

Key Points: 
  • Washington D.C., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Hearing Industries Association (HIA), the only American association to represent hearing aid technology, announces the selection of Bridget Dobyan to serve as Executive Director, effective January 1, 2024, succeeding current President, Kate Carr, who will retire on December 31, 2023.
  • “The HIA Board of Directors is delighted to welcome Ms. Dobyan as the incoming Executive Director,” said Sandy Brandmeier, President of HI Wholesale, Sonova USA.
  • “Her knowledge of the hearing industry coupled with her impressive experience in public policy has been invaluable since joining HIA in 2020.
  • I am fortunate to have worked with Kate and thank her for her guidance and strategic leadership.

LifeWallet Announces It Is In Compliance with All Applicable Nasdaq Listing Standards

Retrieved on: 
Monday, October 30, 2023
CORAL, Eastern Time Zone, Medicare, Hearing, Shareholder, Health insurance, Medicaid

CORAL GABLES, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) ("LifeWallet," or the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced it received correspondence from Nasdaq on Oct 27, 2023 that the Company’s previously disclosed bid price deficiencies have been cured, and that the Company is now in compliance with all applicable Nasdaq listing standards.

Key Points: 
  • CORAL GABLES, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) ("LifeWallet," or the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced it received correspondence from Nasdaq on Oct 27, 2023 that the Company’s previously disclosed bid price deficiencies have been cured, and that the Company is now in compliance with all applicable Nasdaq listing standards.
  • As a result, the scheduled hearing before the Nasdaq Listing Qualifications Hearings Panel on November 2, 2023, has been cancelled.
  • The Company’s Class A common stock will continue to be listed and traded on Nasdaq, subject to continued compliance with applicable Nasdaq listing standards.
  • LifeWallet has also announced it will hold its 2023 Annual Meeting of Stockholders at 10am Eastern Time on Wednesday, November 1, 2023.